General Biotechnology

General Biotechnology

Jinlong Holding Trading Co., Ltd. v. The Individuals, Corporations, Limited Liability Companies, Partnerships and Unincorporated Associates Identified on Schedule A

In the rapidly evolving landscape of pharmaceutical innovation and intellectual property rights, legal battles often serve as a mirror reflecting broader industry trends, challenges, and strategic shifts. The recent case of Jinlong Holding Trading Co.,…

Jinlong Holding Trading Co., Ltd. v. The Individuals, Corporations, Limited Liability Companies, Partnerships and Unincorporated Associates Identified on Schedule A Read Post »

General Biotechnology

The Crystal Ball of Pharma: Using Patent Expiry Data to Build a More Accurate 3-Year Drug Spend Forecast

In the rapidly evolving landscape of pharmaceutical finance, the ability to accurately forecast drug spending is not just a competitive advantage—it’s a necessity. Yet, for years, pharma companies and payers alike have relied on traditional methods tha…

The Crystal Ball of Pharma: Using Patent Expiry Data to Build a More Accurate 3-Year Drug Spend Forecast Read Post »

General Biotechnology

The Ticking Clock: A Complete Guide to Patent Safety and PTAB Challenge Windows in the Pharmaceutical Industry

In the high-stakes world of pharmaceuticals, timing isn’t just everything—it’s the thing. As drug developers race to bring innovative therapies to market, the window to defend their patents can be the difference between blockbuster success and costly s…

The Ticking Clock: A Complete Guide to Patent Safety and PTAB Challenge Windows in the Pharmaceutical Industry Read Post »

Biotechblog
Scroll to Top